Profiling of differential gene expression in Wilms tumor by cDNA expression array

Pediatric Nephrology

Volumn 16, Issue 12, 2001, Pages 1113-1121

  Rigolet, M ^a   Faussillon, M ^a   Baudry, D ^a   Junien, C ^a   Jeanpierre, C ^a  

^a INSERM   (France)

Author keywords

cDNA expression array; Differential gene expression; Wilms tumor

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D2; MATRIX METALLOPROTEINASE;

ANALYSIS; ARTICLE; CANCER THERAPY; CELL HETEROGENEITY; CELL MATURATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FETUS; FETUS (ANATOMY); GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; NEPHROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR CLASSIFICATION;

CYCLINS; FETUS; GENE EXPRESSION PROFILING; HUMANS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; WILMS TUMOR;

EID: 0035664805     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670100040     Document Type: Article

References (50)

1. Histological analysis of aggressiveness and responsiveness in Wilms' tumor
2. Wilms' tumor as a paradigm for the relationship of cancer to development
3. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumor
4. Age distribution of Wilms' tumor: Report from the National Tumor Study
5. Association of Wilms' tumour with aniridia, hemihypertrophy and other congenital malformations
6. A syndrome of pseudohermaphroditism, Wilms' tumour, hypertension, and degenerative renal disease
7. Complexe malformatif familial avec hernie ombilicale et macroglossie. Un syndrome nouveau?
8. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumour locus
9. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping
10. WT-1 is required for early kidney development
11. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome
12. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour
13. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development
14. Identification of constitutional WT1 mutations in patients with isolated diffuse mesangial sclerosis (IDMS) and analysis of genotype-phenotype correlations using a computerized mutation database
15. Multiple roles for the Wilms' tumor suppressor, WT1
16. Infrequent mutation of the WT1 gene in 77 Wilms tumors
17. Fine structure analysis of the WT1 gene in sporadic Wilms tumors
18. Wilms tumor genetics
19. WT1 splicing alterations in Wilms' tumor
20. Evidence for a familial Wilms tumor gene (FWT1) on chromosome 17q12-q21
21. Linkage of familial Wilms tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors
22. Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour
23. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor
24. Characterization of regions of chromosome 12 and 16 involved in nephroblastoma tumorigenesis
25. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination
26. A third Wilms' tumor locus on chromosome 16q
27. Loss of heterozygosity for chromosomes 16q and 1p in Wilms tumors predicts an adverse outcome
28. Involvement of chromosome 7 in Wilms tumor
29. Identifying differences in mRNA expression by representational difference analysis
30. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
31. Serial analysis of gene expression
32. Use of a cDNA microarray to analyse gene expression patterns in human cancer
33. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
34. The transcriptional program in the response of human fibroblasts to serum
35. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymographie in human primary brain tumours
36. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
37. The activation of Pro-MMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form
38. Matrix metalloproteinases in gastrointestinal cancer
39. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis
40. Amplification of cyclin genes in colorectal carcinomas
41. Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2
42. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
43. Co-amplification and overexpression of CDK4, SAS and MDM 2 occurs frequently in human parosteal osteosarcomas
44. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences
45. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumor
46. Molecular and cellular heterogeneity of Wilms' tumor
47. Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor
48. Differential expression of the alpha(2)-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma
49. Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): The integration of genetic and physical maps of the TOC region on 17q25
50. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring